HAYWARD, Calif. — Impax Labs has expanded its senior management team with two appointments.
The generic drug maker said that Mark Fitch has joined the company as SVP operations, while Jeff Nornhold will become SVP quality affairs. Fitch, who joins Impax from Nycomed US, brings more than 35 years of pharmaceutical experience to his role. Nornhold, who most recently served as VP quality operations at drug maker Watson, is a 20-year pharmaceutical industry veteran.
Both Fitch and Nornhold will report to Impax president and CEO Larry Hsu.